Not currently recruiting at University of California Health
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSD
- Dates
- study startestimated completion
- Principal Investigator
- by Adam Burgoyne, MD (ucsd)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Adam Burgoyne, MD (ucsd)
Associate Clinical Professor, Medicine, Vc-health Sciences-schools. Authored (or co-authored) 33 research publications
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Inhibrx, Inc.
- ID
- NCT03715933
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 240 study participants
- Last Updated